Pharmalgen for the treatment of bee and wasp venom allergy

  • Technology appraisal guidance
  • TA246
  • Published: 
Download guidance (PDF)

1 Recommendations

1.1

Pharmalgen is recommended as an option for the treatment of IgE-mediated bee and wasp venom allergy in people who have had:

  • a severe systemic reaction to bee or wasp venom or

  • a moderate systemic reaction to bee or wasp venom and who have 1 or more of the following: a raised baseline serum tryptase, a high risk of future stings or anxiety about future stings.

1.2

Treatment with Pharmalgen should be initiated and monitored in a specialist centre experienced in venom immunotherapy.